NIH-funded research R15 grant

A new biosensor for detecting HIV and Hepatitis viruses in low-resource areas

Official title: A single biosensors for the simultaneous molecular detection of HIV and Hepatitis B and C viruses at resource-limited settings

Funded at University of Central Florida · NIH-11187332 · Data updated 2026-11-12

This study is working on a new, easy-to-use test that can quickly check for HIV, Hepatitis B, and Hepatitis C all at once, especially in places where medical resources are limited, to help more people get diagnosed and treated sooner.

More Hepatitis B research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Central Florida
NIH-funded
Lab location1 site (Orlando, United States)
Project startMarch 1, 2025
Project endFebruary 29, 2028
Funding year2025
Award (this year)$537,619
NIH project number1R15AI189259-01A1
Project IDNIH-11187332 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in resource-limited settings who are at risk for or currently infected with HIV, HBV, or HCV.

Less likely to help

Patients who are not at risk for these infections or who are already receiving effective treatment may not benefit from this research.

What this research studies

This research focuses on developing a novel electrochemical biosensor that can simultaneously detect HIV, Hepatitis B (HBV), and Hepatitis C (HCV) viruses. The approach utilizes advanced technology involving four-way junction probes and isothermal amplification techniques, making it suitable for use in resource-limited settings. By improving diagnostic capabilities, this research aims to address the high rates of undiagnosed and untreated cases of these viruses, particularly in hard-to-reach populations. The goal is to enhance patient outcomes by facilitating earlier diagnosis and treatment.

Why it matters

Potential benefit: If successful, this research could significantly improve the early detection and treatment of HIV and Hepatitis infections, leading to better health outcomes for affected individuals.

How similar studies have gone: Previous research has shown promise in developing biosensors for viral detection, indicating that this approach could lead to significant advancements in diagnostics.

Where this research is happening

  • University of Central Florida
    Orlando, United States
    Active

Researchers

  • Principal investigator: Chumbimuni-Torres, Karin — University of Central Florida
  • Study coordinator: Chumbimuni-Torres, Karin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.